The Society of Thoracic Surgeons (STS) is a not-for-profit organization representing more than 5,400 surgeons, researchers, and allied health professionals worldwide who are dedicated to ensuring the best possible heart, lung, esophageal, and other surgical procedures for the chest. A helpful resource on their website is the section 'STS Patient Information', which is created and maintained by members of STS. It provides detailed information about some of the diseases treated by cardiothoracic surgeons.
The National Cancer Institute (NCI) is part of the United States Federal government's National Institutes of Health with the overall mission of conducting and supporting research, training and disseminating health information with respect to the causes, diagnosis and treatment of cancer. The NCI is a federally funded research and development center, one of eight agencies that compose the Public Health Service in the United States Department of Health and Human Services. This website is extensive and the below links are useful resources for patients with lung or esophageal cancer respectively.
The American Cancer Society (ACS) is the "nationwide community-based voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer, saving lives, and diminishing suffering from cancer, through research, education, advocacy and service." The Society is organized into 14 geographical divisions of both medical and lay volunteers operating in more than 3,400 offices throughout the United States and Puerto Rico. The below links are useful resources for patients with lung or esophageal cancer respectively.
Malignant mesothelioma is a rare cancer caused by inhaling or ingesting asbestos fibers. This cancer occurs in the protective lining of the lungs, abdomen, heart, or other organs. It often takes mesothelioma 20-50 years to develop after asbestos exposure. There are several treatment options for mesothelioma, including chemotherapy, radiation, and surgery. Many patients turn to clinical trials that are exploring promising new treatments like immunotherapy. Treatment options vary based on a patient’s specific diagnosis.